Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MAVRTX · Entity 2875 | VP & Controller | July 24, 2008 | July 25, 2008 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VERTEX PHARMACEUTICALS INC / MA
Report date July 24, 2008 · Filed July 25, 2008
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $32.16 · Expires 2018-07-23 | Direct | 7,500 |
Reported balance
After 2008-07-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2008-07-24 · Grant · Acquired 7,500 · Balance 7,500 F1: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/24/2008. |
Filing footnotes · ownership attribution and instrument terms
F1: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/24/2008.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 12, 2007 Filed Mar 13, 2007 17:51 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $30.00 | $3,750.00 |
DisclosureSEC source: 0000875320-07-000030 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,887 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| March 12, 2007 Filed Mar 13, 2007 17:51 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $11.18 | $1,397.50 |
DisclosureSEC source: 0000875320-07-000030 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,012 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2007 Filed Mar 6, 2007 18:38 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $11.18 | $0.00 |
DisclosureSEC source: 0000875320-07-000028 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 826 Underlying: Common Stock · 125 shares Expires 2009-06-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| March 05, 2007 Filed Mar 6, 2007 18:38 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $30.00 | $3,750.00 |
DisclosureSEC source: 0000875320-07-000028 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,887 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| March 05, 2007 Filed Mar 6, 2007 18:38 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $11.18 | $1,397.50 |
DisclosureSEC source: 0000875320-07-000028 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,012 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2007 Filed Mar 2, 2007 16:06 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 300 | $30.18 | $9,054.00 |
DisclosureSEC source: 0000875320-07-000027 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,887 Read SEC document |
| February 26, 2007 Filed Feb 27, 2007 19:23 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $11.18 | $0.00 |
DisclosureSEC source: 0000875320-07-000026 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 951 Underlying: Common Stock · 125 shares Expires 2009-06-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested. Read SEC document |
| February 26, 2007 Filed Feb 27, 2007 19:23 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $31.63 | $3,953.75 |
DisclosureSEC source: 0000875320-07-000026 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,187 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| February 26, 2007 Filed Feb 27, 2007 19:23 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $11.18 | $1,397.50 |
DisclosureSEC source: 0000875320-07-000026 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2007 Filed Feb 22, 2007 16:35 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 24 | $0.00 Strike: $11.18 | $0.00 |
DisclosureSEC source: 0000875320-07-000025 · edgar.xml · derivative · entry 6 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,076 Underlying: Common Stock · 24 shares Expires 2009-06-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| February 20, 2007 Filed Feb 22, 2007 16:35 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 101 | $0.00 Strike: $10.41 | $0.00 |
DisclosureSEC source: 0000875320-07-000025 · edgar.xml · derivative · entry 5 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,222 Underlying: Common Stock · 101 shares Expires 2015-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 2/3/2005. Read SEC document |
| February 20, 2007 Filed Feb 22, 2007 16:35 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $31.02 | $3,877.50 |
DisclosureSEC source: 0000875320-07-000025 · edgar.xml · nonDerivative · entry 3 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,187 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| February 20, 2007 Filed Feb 22, 2007 16:35 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 24 | $11.18 | $268.32 |
DisclosureSEC source: 0000875320-07-000025 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2007 Filed Feb 22, 2007 16:35 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 101 | $10.41 | $1,051.41 |
DisclosureSEC source: 0000875320-07-000025 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,288 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2007 Filed Feb 13, 2007 17:55 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $10.41 | $0.00 |
DisclosureSEC source: 0000875320-07-000024 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,323 Underlying: Common Stock · 125 shares Expires 2015-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 2/3/2005. Read SEC document |
| February 12, 2007 Filed Feb 13, 2007 17:55 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $31.93 | $3,991.25 |
DisclosureSEC source: 0000875320-07-000024 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,187 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| February 12, 2007 Filed Feb 13, 2007 17:55 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $10.41 | $1,301.25 |
DisclosureSEC source: 0000875320-07-000024 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2007 Filed Feb 6, 2007 20:33 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $10.41 | $0.00 |
DisclosureSEC source: 0000875320-07-000022 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,448 Underlying: Common Stock · 125 shares Expires 2015-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 2/3/2005. Read SEC document |
| February 05, 2007 Filed Feb 6, 2007 20:33 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $32.64 | $4,080.00 |
DisclosureSEC source: 0000875320-07-000022 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,187 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| February 05, 2007 Filed Feb 6, 2007 20:33 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $10.41 | $1,301.25 |
DisclosureSEC source: 0000875320-07-000022 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2007 Filed Feb 2, 2007 17:50 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 300 | $34.85 | $10,455.00 |
DisclosureSEC source: 0000875320-07-000020 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,187 Read SEC document |
| January 29, 2007 Filed Jan 30, 2007 17:47 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $10.41 | $0.00 |
DisclosureSEC source: 0000875320-07-000018 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,573 Underlying: Common Stock · 125 shares Expires 2015-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 2/3/2005. Read SEC document |
| January 29, 2007 Filed Jan 30, 2007 17:47 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $35.20 | $4,400.00 |
DisclosureSEC source: 0000875320-07-000018 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,487 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| January 29, 2007 Filed Jan 30, 2007 17:47 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $10.41 | $1,301.25 |
DisclosureSEC source: 0000875320-07-000018 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,612 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2007 Filed Jan 26, 2007 20:34 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 11,250 | $0.00 Strike: $36.30 | $0.00 |
DisclosureSEC source: 0000875320-07-000013 · edgar.xml · derivative · entry 3 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Stock · 11,250 shares Expires 2017-01-23 F2 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 01/24/2007. Read SEC document |
| January 24, 2007 Filed Jan 26, 2007 20:34 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantCommon Stock | 2,500 | $0.01 | $25.00 |
DisclosureSEC source: 0000875320-07-000013 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,487 F1 · shares: Stock grant made under 2006 Stock and Option Plan, vesting on 1/24/2011, subject to acceleration upon achievement of certain performance-based milestones. Read SEC document |
| January 22, 2007 Filed Jan 24, 2007 21:47 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $10.41 | $0.00 |
DisclosureSEC source: 0000875320-07-000008 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,698 Underlying: Common Stock · 125 shares Expires 2015-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 2/3/2005. Read SEC document |
| January 22, 2007 Filed Jan 24, 2007 21:47 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $36.21 | $4,526.25 |
DisclosureSEC source: 0000875320-07-000008 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,987 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| January 22, 2007 Filed Jan 24, 2007 21:47 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $10.41 | $1,301.25 |
DisclosureSEC source: 0000875320-07-000008 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2007 Filed Jan 17, 2007 22:04 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 125 | $0.00 Strike: $10.41 | $0.00 |
DisclosureSEC source: 0000875320-07-000006 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,085 Underlying: Common Stock · 125 shares Expires 2015-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 2/3/2005. Read SEC document |
| January 16, 2007 Filed Jan 17, 2007 22:04 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $38.31 | $4,788.75 |
DisclosureSEC source: 0000875320-07-000006 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,987 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| January 16, 2007 Filed Jan 17, 2007 22:04 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $10.41 | $1,301.25 |
DisclosureSEC source: 0000875320-07-000006 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2007 Filed Jan 9, 2007 19:05 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 7 | $0.00 Strike: $10.41 | $0.00 |
DisclosureSEC source: 0000875320-07-000004 · edgar.xml · derivative · entry 6 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,210 Underlying: Common Stock · 7 shares Expires 2015-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 2/3/2005. Read SEC document |
| January 08, 2007 Filed Jan 9, 2007 19:05 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 118 | $0.00 Strike: $9.69 | $0.00 |
DisclosureSEC source: 0000875320-07-000004 · edgar.xml · derivative · entry 5 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,217 Underlying: Common Stock · 118 shares Expires 2014-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 16 equal quarterly installments from 3/17/2004. Read SEC document |
| January 08, 2007 Filed Jan 9, 2007 19:05 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $35.28 | $4,410.00 |
DisclosureSEC source: 0000875320-07-000004 · edgar.xml · nonDerivative · entry 3 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,987 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| January 08, 2007 Filed Jan 9, 2007 19:05 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 7 | $10.41 | $72.87 |
DisclosureSEC source: 0000875320-07-000004 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2007 Filed Jan 9, 2007 19:05 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 118 | $9.69 | $1,143.42 |
DisclosureSEC source: 0000875320-07-000004 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,105 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2007 Filed Jan 4, 2007 21:24 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock · Derivative | 125 | $0.00 Strike: $9.69 | $0.00 |
DisclosureSEC source: 0000875320-07-000002 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,335 Underlying: Common Stock · 125 shares Expires 2014-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 20 equal quarterly installments from 3/17/2004. Read SEC document |
| January 03, 2007 Filed Jan 4, 2007 21:24 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 425 | $37.60 | $15,980.00 |
DisclosureSEC source: 0000875320-07-000002 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,987 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| January 03, 2007 Filed Jan 4, 2007 21:24 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $9.69 | $1,211.25 |
DisclosureSEC source: 0000875320-07-000002 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,412 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 26, 2006 Filed Dec 27, 2006 18:57 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock · Derivative | 125 | $0.00 Strike: $9.69 | $0.00 |
DisclosureSEC source: 0000875320-06-000126 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,460 Underlying: Common Stock · 125 shares Expires 2014-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 20 equal quarterly installments from 3/17/2004. Read SEC document |
| December 26, 2006 Filed Dec 27, 2006 18:57 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $37.25 | $4,656.25 |
DisclosureSEC source: 0000875320-06-000126 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,287 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 26, 2006 Filed Dec 27, 2006 18:57 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $9.69 | $1,211.25 |
DisclosureSEC source: 0000875320-06-000126 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,412 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 18, 2006 Filed Dec 19, 2006 16:44 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock · Derivative | 125 | $0.00 Strike: $9.69 | $0.00 |
DisclosureSEC source: 0000875320-06-000122 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,585 Underlying: Common Stock · 125 shares Expires 2014-03-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 20 equal quarterly installments from 3/17/2004. Read SEC document |
| December 18, 2006 Filed Dec 19, 2006 16:44 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 125 | $38.94 | $4,867.50 |
DisclosureSEC source: 0000875320-06-000122 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,287 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 18, 2006 Filed Dec 19, 2006 16:44 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 125 | $9.69 | $1,211.25 |
DisclosureSEC source: 0000875320-06-000122 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,412 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2006 Filed Dec 14, 2006 15:31 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 10 | $38.76 | $387.60 |
DisclosureSEC source: 0000875320-06-000116 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,287 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 11, 2006 Filed Dec 12, 2006 15:46 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock · Derivative | 250 | $0.00 Strike: $9.69 | $0.00 |
DisclosureSEC source: 0000875320-06-000115 · edgar.xml · derivative · entry 4 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,710 Underlying: Common Stock · 250 shares Expires 2014-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan, vesting in 20 equal quarterly installments from 3/17/2004. Read SEC document |
| December 11, 2006 Filed Dec 12, 2006 15:46 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 250 | $40.98 | $10,245.00 |
DisclosureSEC source: 0000875320-06-000115 · edgar.xml · nonDerivative · entry 2 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,297 F1 · kind: Transaction made pursuant to Ms. Messina-Power's company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 11, 2006 Filed Dec 12, 2006 15:46 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 250 | $9.69 | $2,422.50 |
DisclosureSEC source: 0000875320-06-000115 · edgar.xml · nonDerivative · entry 1 POWER JOHANNA MESSINA · CIK 0001197030 · VP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.